×
About 128 results

ALLMedicine™ Adult Brain Tumor Center

Research & Reviews  46 results

Impact of COVID-19 on adolescent and emerging adult brain tumor survivors and their par...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209896
Pediatric Blood & Cancer; Fisher AP, Patronick J et. al.

May 25th, 2021 - The COVID-19 pandemic has prompted unprecedented challenges, contributing to greater difficulties among families of children with special health care needs, such as pediatric brain tumor survivors. We examined the impact of the pandemic on psychos...

Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide re...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096095
PloS One; Williford SE, Libby CJ et. al.

May 5th, 2021 - Treatment for the lethal primary adult brain tumor glioblastoma (GBM) includes the chemotherapy temozolomide (TMZ), but TMZ resistance is common and correlates with promoter methylation of the DNA repair enzyme O-6-methylguanine-DNA methyltransfer...

Commentary: Post-Acute Cognitive Rehabilitation for Adult Brain Tumor Patients.
https://doi.org/10.1093/neuros/nyab064
Neurosurgery Sefcikova V, Christofi G et. al.

Mar 26th, 2021 - Commentary: Post-Acute Cognitive Rehabilitation for Adult Brain Tumor Patients.|2021|Sefcikova V,Christofi G,Samandouras G,|

Postacute Cognitive Rehabilitation for Adult Brain Tumor Patients.
https://doi.org/10.1093/neuros/nyaa552
Neurosurgery Weyer-Jamora C, Brie MS et. al.

Feb 16th, 2021 - Intrinsic brain tumors often occur within functional neural networks, leading to neurological impairment and disability of varying degrees. Advances in our understanding of tumor-network integration, human cognition and language processing, and mu...

Patient-reported functional executive challenges and caregiver confirmation in adult br...
https://doi.org/10.1007/s11764-020-00961-0
Journal of Cancer Survivorship : Research and Practice; Cantisano N, Menei P et. al.

Oct 28th, 2020 - The main objective of this study was to provide further information concerning the validity of patient-reported executive function (EF) in survivors of primary brain tumor (PBT) compared with a report provided by each patient's caregiver. Forty su...

see more →

Clinicaltrials.gov  2 results

Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor
https://clinicaltrials.gov/ct2/show/NCT01326104

Apr 24th, 2020 - Malignant brain tumors now represent the most frequent cause of cancer death in children. Despite aggressive and highly toxic multi-modality therapy including surgery, craniospinal radiation, and high-dose chemotherapy coupled with peripheral bloo...

A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
https://clinicaltrials.gov/ct2/show/NCT02490930

Sep 13th, 2017 - Five evaluable patients with newly diagnosed high grade gliomas who will undergo standard concomitant radiation and temozolomide followed by adjuvant temozolomide will be accrued to this open-label, single arm, safety study. Oral fingolimod will b...

see more →

News  3 results

Donepezil Helps Some Patients Treated With Brain Irradiation
https://www.medscape.com/viewarticle/844002

Apr 30th, 2015 - Donepezil (multiple brands), a drug commonly used for Alzheimer's disease, improved some measures of cognitive functioning in patients with brain tumors treated with brain irradiation, according to results from a phase 3 clinical trial published A...

Alzheimer’s drug improves cognitive function after RT for brain tumors
https://www.mdedge.com/neurology/article/98906/alzheimers-cognition/alzheimers-drug-improves-cognitive-function-after-rt
Jennifer Kelly Shepphird

Apr 20th, 2015 - Adult brain tumor survivors taking donepezil, a drug approved for the treatment of Alzheimer’s disease, showed significant improvements in the cognitive functions of memory, motor speed, and dexterity, compared with those taking a placebo. However.

Gene and Pathway Alterations Identified in Both Glioblastoma Multiforme and Pancreatic Cancer
https://www.medscape.com/viewarticle/580110

Sep 5th, 2008 - September 5, 2008 — A trio of genomic studies published yesterday in Nature and Science point to specific genes and signaling pathways that characterize 2 human cancers. The results suggest a potential for targeted therapies in glioblastoma multif...

see more →